Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Antiproliferative and quinone reductase-inducing activities of withanolides derivatives.
Eur J Med Chem. 2014 Jul 23;82:68-81. doi: 10.1016/j.ejmech.2014.05.045. Epub 2014 May 20.
Eur J Med Chem. 2014.
PMID: 24878636
Synthesis and induction of apoptosis signaling pathway of ent-kaurane derivatives.
Hueso-Falcón I, Girón N, Velasco P, Amaro-Luis JM, Ravelo AG, de las Heras B, Hortelano S, Estevez-Braun A.
Hueso-Falcón I, et al.
Bioorg Med Chem. 2010 Feb 15;18(4):1724-35. doi: 10.1016/j.bmc.2009.11.064. Epub 2009 Dec 6.
Bioorg Med Chem. 2010.
PMID: 20116261
Item in Clipboard
Synthesis and anti-inflammatory activity of ent-kaurene derivatives.
Hueso-Falcón I, Cuadrado I, Cidre F, Amaro-Luis JM, Ravelo AG, Estevez-Braun A, de Las Heras B, Hortelano S.
Hueso-Falcón I, et al.
Eur J Med Chem. 2011 Apr;46(4):1291-305. doi: 10.1016/j.ejmech.2011.01.052. Epub 2011 Feb 3.
Eur J Med Chem. 2011.
PMID: 21334121
Item in Clipboard
Synthesis and biological evaluation of naphthoquinone-coumarin conjugates as topoisomerase II inhibitors.
Hueso-Falcón I, Amesty Á, Anaissi-Afonso L, Lorenzo-Castrillejo I, Machín F, Estévez-Braun A.
Hueso-Falcón I, et al.
Bioorg Med Chem Lett. 2017 Feb 1;27(3):484-489. doi: 10.1016/j.bmcl.2016.12.040. Epub 2016 Dec 22.
Bioorg Med Chem Lett. 2017.
PMID: 28040393
Item in Clipboard
CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia.
Guerra B, Martín-Rodríguez P, Díaz-Chico JC, McNaughton-Smith G, Jiménez-Alonso S, Hueso-Falcón I, Montero JC, Blanco R, León J, Rodríguez-González G, Estévez-Braun A, Pandiella A, Díaz-Chico BN, Fernández-Pérez L.
Guerra B, et al. Among authors: hueso falcon i.
Oncotarget. 2017 May 2;8(18):29679-29698. doi: 10.18632/oncotarget.11425.
Oncotarget. 2017.
PMID: 27557509
Free PMC article.
Item in Clipboard
A Novel Naphthoquinone-Coumarin Hybrid That Inhibits BCR-ABL1-STAT5 Oncogenic Pathway and Reduces Survival in Imatinib-Resistant Chronic Myelogenous Leukemia Cells.
Martín-Rodríguez P, Guerra B, Hueso-Falcón I, Aranda-Tavío H, Díaz-Chico J, Quintana J, Estévez F, Díaz-Chico B, Amesty A, Estévez-Braun A, Fernández-Pérez L.
Martín-Rodríguez P, et al. Among authors: hueso falcon i.
Front Pharmacol. 2019 Jan 9;9:1546. doi: 10.3389/fphar.2018.01546. eCollection 2018.
Front Pharmacol. 2019.
PMID: 30687103
Free PMC article.
Item in Clipboard
Correction: CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia.
Guerra B, Martín-Rodríguez P, Díaz-Chico JC, McNaughton-Smith G, Jiménez-Alonso S, Hueso-Falcón I, Montero JC, Blanco R, León J, Rodríguez-González G, Estévez-Braun A, Pandiella A, Díaz-Chico BN, Fernández-Pérez L.
Guerra B, et al. Among authors: hueso falcon i.
Oncotarget. 2018 Aug 14;9(63):32272. doi: 10.18632/oncotarget.26008. eCollection 2018 Aug 14.
Oncotarget. 2018.
PMID: 30181817
Free PMC article.
Item in Clipboard
Cite
Cite